CONNECT WITH US
Gaming

Gaming

'Common Side Effects' Officially Break Their Silence on Season 2 Plans

Polygon logo

Published on

Add as a preferred source on Google
'Common Side Effects' Officially Break Their Silence on Season 2 Plans

Polygon sat down with Joe Bennet and Steve Hely ahead of their big New York Comic Con announcement

Common Side Effects was an unexpected treat when it premiered in February 2025. Featuring trippy animation and the voice of Hank Hill himself (Mike Judge), the series follows a schlubby fungus expert named Marshall Cuso (Dave King) who discovers a rare species of "Blue Angel" mushroom that can seemingly cure any disease or physical injury. Marshall's discovery sets off a conspiracy thriller as both the federal government and the pharmaceutical industry race to find Marshall and take control of this once-in-a-lifetime opportunity.

The Adult Swim series was also a redemption of sorts for co-creator Joe Bennett, after his previous project, Scavengers Reign, was canceled by HBO Max, offloaded to Netflix, and then shelved again. So it comes as a relief that Bennett's Common Side Effects, which he co-created with Steve Hely (Veep), is getting a second season.

At a New York Comic Con 2026 panel, Bennett and Hely announced that Common Side Effects season 2 will debut Sunday, Jan. 24 at 11:00 p.m. ET on Adult Swim (and streaming the next day on HBO Max). Ahead of the announcement, Polygon was able to watch the first episode of season 2 and ask its creators a few questions about where the show is headed next.

Check out our conversation below, along with a few updates on Bennett's other animated projects.

There are light spoilers for Common Side Effects season 2 episode 1 in this article.


Source link
Related Topics:Gaming

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.